Skip to main content
AB

Ark Biotech

Provides a virtual bioreactor platform that uses multiphysics modeling to simulate thousands of upstream cell culture experiments, enabling researchers to explore complex bioprocess parameters without physical constraints. This approach reduces development time and risk by delivering high-fidelity data and predictive insights for optimizing bioprocess workflows.

Cambridge, United KingdomFounded 2021193K+ followers
Updated 4 months ago

Funding

$16.7M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

Product

Problem

Biopharmaceutical companies face challenges in optimizing cell culture processes due to the complexity and high cost of running numerous physical experiments. Traditional methods are time-consuming, resource-intensive, and limit the exploration of the bioprocess parameter space.

Solution

Ark Biotech offers a virtual bioreactor platform that leverages multiphysics modeling to simulate thousands of upstream cell culture experiments. This in silico approach allows researchers to explore a wide range of bioprocess parameters and conditions without the constraints of physical experimentation. The platform provides high-fidelity data and predictive insights, enabling data-driven decision-making and accelerated bioprocess development. By democratizing computational tools, Ark Biotech empowers innovators to optimize bioprocess workflows, reduce development time, and de-risk the overall bioprocess.

Target Audience

The primary target audience includes biopharmaceutical companies, researchers, and scientists involved in upstream cell culture process development and optimization.

Features

  • High-fidelity multiphysics models that capture complex dynamics of upstream cell culture
  • Virtual bioreactor environment for simulating thousands of experiments in silico
  • Predictive insights for optimizing bioprocess workflows and reducing development time
  • Ability to test complex hypotheses and recipes with minimal activation energy
  • Streamlined experimentation with an intelligent bioreactor system
This profile is AI-generated and may contain inaccuracies.